SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 114.02 |
| Enterprise Value ($M) | -34.96 |
| Book Value ($M) | 166.64 |
| Book Value / Share | 3.46 |
| Price / Book | 0.68 |
| NCAV ($M) | 145.44 |
| NCAV / Share | 3.02 |
| Price / NCAV | 0.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.11 |
| Return on Assets (ROA) | -0.12 |
| Return on Equity (ROE) | -0.13 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.55 |
| Current Ratio | 3.55 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 202.55 |
| Assets | 223.75 |
| Liabilities | 57.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nachtrab Matthew | |||
| 13G/A | Barbier Remi | 4.20 | -17.00 | |
| 13G/A | Vanguard Group Inc | 5.51 | 5.81 | |
| 13G/A | BlackRock, Inc. | 7.20 | 18.44 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 274,568 | 981,612 | 27.97 | |
| 333,154 | 916,134 | 36.37 | |
| 297,303 | 940,371 | 31.62 | |
| 270,645 | 994,595 | 27.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RVPH – Reviva Pharmaceuticals Holdings, Inc. | RZLT – Rezolute, Inc. |
| SABS – SAB Biotherapeutics, Inc. | SBFM – Sunshine Biopharma, Inc. |
| SCLX – Scilex Holding Company |